Ocumetics Technology Corp - Asset Resilience Ratio
Ocumetics Technology Corp (OTC) has an Asset Resilience Ratio of 0.00% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Ocumetics Technology Corp to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2023–2025)
This chart shows how Ocumetics Technology Corp's Asset Resilience Ratio has changed over time. See OTC net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Ocumetics Technology Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see OTC market cap overview.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0% |
| Short-term Investments | CA$0.00 | 0% |
| Total Liquid Assets | CA$0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Ocumetics Technology Corp maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Ocumetics Technology Corp Industry Peers by Asset Resilience Ratio
Compare Ocumetics Technology Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087 |
Medical Instruments & Supplies | 9.87% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
Tarsons Products Limited
NSE:TARSONS |
Medical Instruments & Supplies | 0.47% |
|
SciVision Biotech Inc
TW:1786 |
Medical Instruments & Supplies | 7.81% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
Annual Asset Resilience Ratio for Ocumetics Technology Corp (2023–2025)
The table below shows the annual Asset Resilience Ratio data for Ocumetics Technology Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.00% | CA$0.00 ≈ $0.00 |
CA$1.90 Million ≈ $1.38 Million |
-- |
| 2024-12-31 | 59.35% | CA$1.38 Million ≈ $997.37K |
CA$2.32 Million ≈ $1.68 Million |
-- |
| 2023-12-31 | 0.00% | CA$0.00 ≈ $0.00 |
CA$1.04 Million ≈ $749.74K |
-- |
About Ocumetics Technology Corp
Ocumetics Technology Corp. engages in research, development, production, and sale of vision enhancement products in Canada. It develops expandable intraocular lenses to eliminate the need for corrective lenses primarily for people over 45 years of age. The company was formerly known as Quantum Blockchain Technologies Ltd. and changed its name to Ocumetics Technology Corp. in August 2021. The comp… Read more